Effects of imiglucerase on the growth and metabolism of Gaucher disease type I patients: a systematic review (Q38097497)

28 August 2017

Effects of imiglucerase on the growth and metabolism of Gaucher disease type I patients: a systematic review (English)

1 reference

28 August 2017

1 reference

1 reference

Ida Vanessa D Schwartz

4

0 references

author name string

Divair Doneda

1

1 reference

28 August 2017

Cristina B Netto

2

1 reference

28 August 2017

Cileide C Moulin

3

1 reference

28 August 2017

9 April 2013

1 reference

28 August 2017

Nutrition and Metabolism

1 reference

28 August 2017

10

1 reference

28 August 2017

1

1 reference

28 August 2017

34

1 reference

Gaucher's Disease in Albanian Children: Casuistics and Treatment

28 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630065

A reappraisal of Gaucher disease-diagnosis and disease management algorithms.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630065

Outcome of enzyme replacement therapy in patients with Gaucher disease type I. The Romanian experience

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630065

Clinical consequences of interrupting enzyme replacement therapy in children with type 1 Gaucher disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630065

The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630065

Therapeutic goals in the treatment of Gaucher disease.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630065

Imiglucerase low-dose therapy for paediatric Gaucher disease--a long-term cohort study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630065

Pediatric non-neuronopathic Gaucher disease: presentation, diagnosis and assessment. Consensus statements

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630065

Enzyme replacement therapy for Gaucher's disease: the early Canadian experience

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630065

Adult-type Gaucher disease in children: genetics, clinical features and enzyme replacement therapy.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630065

Enzyme replacement treatment in type 1 and type 3 Gaucher's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630065

Gaucher disease type I: Assessment of basal metabolic rate in patients from southern Brazil

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630065

Type 1 Gaucher Disease: Phenotypic Expression and Natural History in Japanese Patients

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630065

Acceleration of retarded growth in children with Gaucher disease after treatment with alglucerase

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630065

Resting energy expenditure in Gaucher's disease type 1: effect of Gaucher's cell burden on energy requirements

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630065

Eight-year clinical outcomes of long-term enzyme replacement therapy for 884 children with Gaucher disease type 1.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630065

Plasma glucosylceramide and ceramide in type 1 Gaucher disease patients: correlations with disease severity and response to therapeutic intervention.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630065

Type I Gaucher disease, a glycosphingolipid storage disorder, is associated with insulin resistance

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630065

12 A practical approach to diagnosis and management of Gaucher's disease

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630065

Increased basal glucose production in type 1 Gaucher's disease

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630065

Very low serum adiponectin levels in patients with type 1 Gaucher disease without overt hyperglycemia

31 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186/1743-7075-10-34

Overweight, insulin resistance and type II diabetes in type I Gaucher disease patients in relation to enzyme replacement therapy

21 January 2018

1 reference

12 December 2020

Differential effects of enzyme supplementation therapy on manifestations of type 1 Gaucher disease

1 reference

12 December 2020

Type I Gaucher disease in children with and without enzyme therapy

1 reference

12 December 2020

Gaucher disease: recommendations on diagnosis, evaluation, and monitoring

1 reference

12 December 2020

Gaucher disease: lessons from a decade of therapy

1 reference

12 December 2020

Insulin-like growth factors in childhood-onset Gaucher disease

1 reference

12 December 2020

[Clinical and nutritional aspects of Gaucher disease: prospective study of 13 children at a single center]

1 reference

12 December 2020

Delayed growth and puberty in patients with Gaucher disease type 1: natural history and effect of splenectomy and/or enzyme replacement therapy

1 reference

12 December 2020

Hypermetabolism in Gaucher disease type I is not associated with altered thyroid hormone levels

1 reference

12 December 2020

Prominent increase in plasma ganglioside GM3 is associated with clinical manifestations of type I Gaucher disease

1 reference

12 December 2020

Phenotype and mutational spectrum in Tunisian pediatric gaucher disease

1 reference

12 December 2020

A cross-sectional, mono-centric pilot study of insulin resistance in enzyme replacement therapy patients with Gaucher type I without overweight

1 reference

12 December 2020

Identifiers

DOI

10.1186/1743-7075-10-34

1 reference

Dimensions Publication ID

28 August 2017

0 references

1 reference

28 August 2017

PubMed publication ID

23570288

1 reference